[1]
C. Delcher, PhD, Y. Wang, MS, H. W. Young, MD, B. A. Goldberger, PhD, S. Schmidt, MD, PhD, FAAFP, and G. M. Reisfield, MD, “Trends in Florida’s Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use”, J of Opioid Management, vol. 13, no. 5, pp. 283–289, Sep. 2017.